Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

GABA mechanisms and sleep.

Claude Gottesmann1

  • 1Laboratoire de Psychophysiologie, Faculté des Sciences, Université de Nice-Sophia Antipolis, 06108 Nice Cedex 2, France. gottesma@unice.fr

Neuroscience
|May 2, 2002
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

The involvement of noradrenaline in rapid eye movement sleep mentation.

Frontiers in neurology·2011
Same author

The development of the science of dreaming.

International review of neurobiology·2010
Same author

To what extent do neurobiological sleep-waking processes support psychoanalysis?

International review of neurobiology·2010
Same author

Discovery of the dreaming sleep stage: a recollection.

Sleep·2009
Same author

Noradrenaline involvement in basic and higher integrated REM sleep processes.

Progress in neurobiology·2008
Same author

The neurobiological characteristics of rapid eye movement (REM) sleep are candidate endophenotypes of depression, schizophrenia, mental retardation and dementia.

Progress in neurobiology·2007

Gamma-aminobutyric acid (GABA) influences sleep and waking via GABA receptors. New GABA(C) receptor drugs may offer novel therapies for sleep disorders and epilepsy with fewer side effects.

Area of Science:

  • Neuroscience
  • Pharmacology

Background:

  • Gamma-aminobutyric acid (GABA) is the primary inhibitory neurotransmitter in the central nervous system (CNS).
  • GABA receptors, specifically GABA(A), are known targets for hypnotic drugs that modulate sleep-wake cycles.
  • Existing hypnotic generations (barbiturates, benzodiazepines, imidazopyridines, cyclopyrrolones) primarily target GABA(A) receptors.

Purpose of the Study:

  • To review the influence of molecules acting on GABA receptors on sleep and waking.
  • To explore the potential of novel GABA receptor modulators, particularly targeting GABA(C) receptors, for therapeutic applications.

Main Methods:

  • Review of existing literature on GABA receptor function and pharmacology related to sleep and waking.
  • Analysis of the effects of different generations of hypnotics on sleep stages.

Related Experiment Videos

  • Examination of studies involving GABA(B) and GABA(C) receptor antagonists.

    • Main Results:

    • GABA(A) receptor activation promotes sleep; its modulators affect waking and sleep stages differently.
    • GABA(B) receptor antagonists increase waking and paradoxical sleep.
    • GABA(C) receptor antagonists increase waking at the expense of other sleep stages.

    Conclusions:

    • GABA(C) receptors exhibit higher sensitivity to GABA than GABA(A) and GABA(B) receptors.
    • GABA(C) receptor agonists and antagonists hold promise for treating insomnia, epilepsy, and narcolepsy.
    • Future therapies targeting GABA(C) receptors may offer lower doses and fewer side effects compared to current treatments.